1. Canada Stocks

  2. •

    Healthcare

  3. •

    Medical - Care Facilities
Imagin Medical Inc.

Imagin Medical Inc.

IMEXF
Imagin Medical Inc.US flagOther OTC
0.00
USD
- -
- -
1,083.00Market Cap
Imagin Medical Inc.
IMEXF
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
-17.08
-55.5
-35.77
-0.41
-8.78
-9.9
-2.54
-10.36
-1.3
-1.68
-0.63
-1.48
-0.64
-0.53
-1.27
-0.25
-0.31
Basic EPS, GAAP
-40.69
-23.68
-4.58
-6.95
-10.57
-6.99
-3.3
-3.38
-0.55
-1.15
-0.27
-0.86
-0.59
-0.5
-0.45
-0.34
-0.16
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-70.14
-116.58
-143.55
-147.63
-142.56
-139.72
-140.2
-150.27
-1.3
-0.41
-0.59
0.59
-0.11
-0.4
-1.61
-1.65
-1.4
Book Value per Share
101.11
57.81
18.18
18.22
24.82
13.97
11.51
1.17
-0.28
-0.01
-0.26
1.09
0.28
-0.06
-1.29
-1.45
-1.19
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
2
5
7
8
9
10
11
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
-2
-8
-6
- -
-2
-2
- -
-2
- -
-2
-2
-8
-4
-4
-11
-2
-3
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
1
1
1
3
2
1
- -
- -
- -
-1
6
2
- -
-12
-15
-13
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
13
8
3
3
4
3
2
- -
- -
- -
-1
6
2
- -
-12
-13
-12
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
122.27
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'23
Mar'23
Jun'23
ST Debt
13
14
11
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
11
11
11
Market Capitalization
3
2
1

Working Capital

FRC

•

in mil. unless spec.
Dec'23
Mar'23
Jun'23
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
15
15
13
Payables & Accruals
2
2
2
ST Debt
13
14
11
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
78,681.44%
390.44%
15.55%
Free Cash Flow
652.38%
112.67%
-16.9%
Net Income, GAAP
433.98%
90.82%
-78.28%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
-0.06
-0.26
-0.05
- -
-1.27
2022
-0.14
-0.11
0.46
- -
-0.25
2023
- -
-0.08
0.2
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
Similar Companies
Surgery Partners, Inc. (SGRY)
PT Metro Healthcare Indonesia Tbk (CARE.JK)
PT Kedoya Adyaraya Tbk (RSGK.JK)
Selectis Health, Inc. (GBCS)
Canadian General Medical Center Complex Company (9518.SR)
Lotus Eye Hospital and Institute Limited (LOTUSEYE.NS)
Business
Imagin Medical Inc. develops and commercializes surgical imaging and ablation technologies for the visualization and treatment of urologic cancers, including bladder and prostate cancer, through minimally invasive procedures; its core products comprise the i/Blue Imaging System, which employs advanced proprietary optics, light sensors, and dual white-blue light imaging with fluorescent agents to enhance detection accuracy and reduce bladder cancer recurrence rates by up to 33 percent compared to standard white light endoscopy; and the enCAGE Coil Precision Ablation System, a bipolar radiofrequency device that creates a targeted electromagnetic field to ablate prostate cancer tissue while sparing surrounding nerves and structures to minimize erectile dysfunction and urinary incontinence. The company, founded in 1986 and headquartered at 890 West Pender Street, Suite 600, Vancouver, British Columbia, Canada V6C 1L9, operates primarily in North America with a focus on urologists and healthcare institutions treating urologic oncology patients. In August 2022, Imagin Medical acquired the enCAGE Coil technology from Trod Medical NV for up to US$2.5 million in milestone-based payments and secured a US$7.25 million convertible note financing led by Rapha Capital BioVentures Fund I, LP and Bigger Capital to fund its development toward FDA 510(k) clearance; the company also raised an additional $3 million convertible note in a subsequent financing led by Rapha Capital, appointed Kayvon Namvar to its board and named Kevin Slawin, M.D. as chairman in November 2021, and provided a product and financial update in January 2024 amid ongoing progress toward commercialization.

Company News

APIChatGPT

  • prnewswire.com

    Rapha Capital Leads New $3 Million Convertible Note Financing in Imagin Medical, Inc.

  • globenewswire.com

    Imagin Medical Secures New $3 Million Convertible Note Financing

  • globenewswire.com

    Imagin Medical on Schedule for American Urology Association Demonstration

  • globenewswire.com

    IMAGIN MEDICAL REPORTS COMPANY ON SCHEDULE FOR PRODUCT DEMONSTRATION

  • globenewswire.com

    IMAGIN MEDICAL REPORTS MANUFACTURING PROGESS

  • globenewswire.com

    IMAGIN MEDICAL CLOSES SECOND TRANCHE OF CONVERTIBLE NOTE OFFERING

  • globenewswire.com

    Imagin Medical Engages Torrey Hills Capital